Codiak today announced that Benny Sorensen, M.D., Ph.D. resigned from his position as a Senior Vice President of Strategic Projects to become CEO of a privately held biotech company, Hemab Therapeutics, focused on rare bleeding and thrombosis disorders.
Jazz Pharmaceuticals has announced a collaboration with Codiak Biosciences to research, develop and commercialise cancer therapies created through engineering exosomes......